Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 19 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-03-10 | 2017-04-10 | 324 |
| APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-10 | 658 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-07 | 113 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2017-03-11 | 2017-04-07 | 426 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 83 |
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 80 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 712 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 709 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 55 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 33 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 86 |
| APO-MEMANTINE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 381 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-12 | 2017-04-04 | 674 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-10 | 2017-04-04 | 408 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-04 | 592 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 67 |
| APO-OXYBUTYNIN | 5 MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 414 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-01 | 384 |
| APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-01 | 387 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-FUROSEMIDE | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
| APO-FUROSEMIDE | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
| APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
| APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |